Grossman W - Search Results

1

Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial.

Colevas AD, Bahleda R, Braiteh F, Balmanoukian A, Brana I, Chau NG, Sarkar I, Molinero L, Grossman W, Kabbinavar F, Fassò M, O'Hear C, Powderly J. Colevas AD, et al. Among authors: grossman w. Ann Oncol. 2018 Nov 1;29(11):2247-2253. doi: 10.1093/annonc/mdy411. Ann Oncol. 2018. PMID: 30219915 Free article. Clinical Trial.

2

Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.

Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J. Lukas RV, et al. Among authors: grossman w. J Neurooncol. 2018 Nov;140(2):317-328. doi: 10.1007/s11060-018-2955-9. Epub 2018 Aug 2. J Neurooncol. 2018. PMID: 30073642 Clinical Trial.

3

Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study.

Horn L, Gettinger SN, Gordon MS, Herbst RS, Gandhi L, Felip E, Sequist LV, Spigel DR, Antonia SJ, Balmanoukian A, Cassier PA, Liu B, Kowanetz M, O'Hear C, Fassò M, Grossman W, Sandler A, Soria JC. Horn L, et al. Among authors: grossman w. Eur J Cancer. 2018 Sep;101:201-209. doi: 10.1016/j.ejca.2018.06.031. Epub 2018 Aug 1. Eur J Cancer. 2018. PMID: 30077125 Clinical Trial.

4

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.

Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, Kuter I, Nanda R, Cassier PA, Delord JP, Gordon MS, ElGabry E, Chang CW, Sarkar I, Grossman W, O'Hear C, Fassò M, Molinero L, Schmid P. Emens LA, et al. Among authors: grossman w. JAMA Oncol. 2019 Jan 1;5(1):74-82. doi: 10.1001/jamaoncol.2018.4224. JAMA Oncol. 2019. PMID: 30242306 Free PMC article. Clinical Trial.

5

Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.

Zhang Y, Sievers RE, Prasad M, Mirsky R, Shih H, Wong ML, Angeli FS, Ye J, Takagawa J, Koskenvuo JW, Springer ML, Grossman W, Boyle AJ, Yeghiazarians Y. Zhang Y, et al. Among authors: grossman w. Cardiovasc Pathol. 2011 Jul-Aug;20(4):204-12. doi: 10.1016/j.carpath.2010.06.007. Epub 2010 Jul 29. Cardiovasc Pathol. 2011. PMID: 20667749

6

Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy.

Angeli FS, Shapiro M, Amabile N, Orcino G, Smith CS, Tacy T, Boyle AJ, Chatterjee K, Glantz SA, Grossman W, Yeghiazarians Y. Angeli FS, et al. Among authors: grossman w. Comp Med. 2009 Jun;59(3):272-9. Comp Med. 2009. PMID: 19619418 Free PMC article.

7

Granulocyte colony stimulating factor in myocardial infarction with low ejection fraction.

Angeli FS, Smith C, Amabile N, Shapiro M, Bartlett L, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y. Angeli FS, et al. Among authors: grossman w. Cytokine. 2010 Sep;51(3):278-85. doi: 10.1016/j.cyto.2010.06.003. Epub 2010 Jul 6. Cytokine. 2010. PMID: 20609597

8

Prolonged therapy with erythropoietin is safe and prevents deterioration of left ventricular systolic function in a porcine model of myocardial infarction.

Angeli FS, Amabile N, Burjonroppa S, Shapiro M, Bartlett L, Zhang Y, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y. Angeli FS, et al. Among authors: grossman w. J Card Fail. 2010 Jul;16(7):579-89. doi: 10.1016/j.cardfail.2010.02.008. Epub 2010 Apr 3. J Card Fail. 2010. PMID: 20610234

9

Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction.

Yeghiazarians Y, Khan M, Angeli FS, Zhang Y, Jahn S, Prasad M, Mirsky R, Shih H, Minasi P, Boyle A, Grossman W. Yeghiazarians Y, et al. Among authors: grossman w. J Card Fail. 2010 Aug;16(8):669-78. doi: 10.1016/j.cardfail.2010.03.008. Epub 2010 May 4. J Card Fail. 2010. PMID: 20670846

10

Cytokine combination therapy with erythropoietin and granulocyte colony stimulating factor in a porcine model of acute myocardial infarction.

Angeli FS, Amabile N, Shapiro M, Mirsky R, Bartlett L, Zhang Y, Virmani R, Chatterjee K, Boyle A, Grossman W, Yeghiazarians Y. Angeli FS, et al. Among authors: grossman w. Cardiovasc Drugs Ther. 2010 Dec;24(5-6):409-20. doi: 10.1007/s10557-010-6263-7. Cardiovasc Drugs Ther. 2010. PMID: 20809214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

374 results

Search Page